Trials / Completed
CompletedNCT03086278
A Study of AST-008 in Healthy Subjects
A Randomized, Combined SAD/MAD Phase 1 Study of the Safety, Pharmacokinetics and Pharmacodynamics of AST 008 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Exicure, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
AST-008 will be dosed subcutaneously to healthy volunteers in a combined SAD/MAD study to evaluate its safety, tolerability, pharmacokinetics and pharmacodynamics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AST-008 | AST-008 is a toll-like receptor 9 agonist. |
Timeline
- Start date
- 2017-10-20
- Primary completion
- 2018-08-16
- Completion
- 2018-08-16
- First posted
- 2017-03-22
- Last updated
- 2018-09-25
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03086278. Inclusion in this directory is not an endorsement.